Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shi-Dan Zhou"'
Autor:
Chong Chen, Chao-Yue Cui, Jun-Jun Yu, Qian He, Xiao-Ting Wu, Yu-Zhang He, Ze-Hua Cui, Cang Li, Qiu-Lin Jia, Xiang-Guang Shen, Ruan-Yang Sun, Xi-Ran Wang, Min-Ge Wang, Tian Tang, Yan Zhang, Xiao-Ping Liao, Barry N. Kreiswirth, Shi-Dan Zhou, Bin Huang, Hong Du, Jian Sun, Liang Chen, Ya-Hong Liu
Publikováno v:
Genome Medicine, Vol 12, Iss 1, Pp 1-13 (2020)
Abstract Background The recent emergence and dissemination of high-level mobile tigecycline resistance Tet(X) challenge the clinical effectiveness of tigecycline, one of the last-resort therapeutic options for complicated infections caused by multidr
Externí odkaz:
https://doaj.org/article/3f4569410a96470a80daeb2dc6a8cd85
Autor:
Jian Sun, Ya Hong Liu, Youjun Feng, Bin Huang, Liang Xing Fang, Yan Zhang, Ze Hua Cui, Han Mian Liu, You-Zhi Tang, Chao Yue Cui, Barry N. Kreiswirth, Liang Chen, Fang You Yu, Xiao Liu, Chong Chen, Barun Mathema, Xiao Yu Ma, Xin Lei Lian, Zhi Hui Zhuang, Kou Xing Zhang, Shi Dan Zhou, Hong Du, Jing Lv, Xiao-Ping Liao, Rong Min Zhang
Publikováno v:
Nature microbiology
Tigecycline is one of the last-resort antibiotics to treat complicated infections caused by both multidrug-resistant Gram-negative and Gram-positive bacteria1. Tigecycline resistance has sporadically occurred in recent years, primarily due to chromos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3c150d4895f60136934c5ff0daec16f
https://doi.org/10.1038/s41564-019-0496-4
https://doi.org/10.1038/s41564-019-0496-4
Autor:
Liang Chen, Qiu Lin Jia, Ya Hong Liu, Xi Ran Wang, Chong Chen, Xiao-Ping Liao, Yan Zhang, Min Ge Wang, Jun Jun Yu, Tang Tian, Bin Huang, Ze Hua Cui, Shi Dan Zhou, Ruan Yang Sun, Cang Li, Jian Sun, Chao Yue Cui, Yu Zhang He, Qian He, Hong Du, Xiang Guang Shen, Xiao Ting Wu, Barry N. Kreiswirth
Publikováno v:
Genome Medicine
Genome Medicine, Vol 12, Iss 1, Pp 1-13 (2020)
Genome Medicine, Vol 12, Iss 1, Pp 1-13 (2020)
Background The recent emergence and dissemination of high-level mobile tigecycline resistance Tet(X) challenge the clinical effectiveness of tigecycline, one of the last-resort therapeutic options for complicated infections caused by multidrug-resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30959e6378566ec362cfc278fc658351
https://pubmed.ncbi.nlm.nih.gov/33287863
https://pubmed.ncbi.nlm.nih.gov/33287863
Autor:
Chen, Chong, Chao-Yue Cui, Yu, Jun-Jun, He, Qian, Wu, Xiao-Ting, Yu-Zhang He, Cui, Ze-Hua, Li, Cang, Jia, Qiu-Lin, Xiang-Guang Shen, Ruan-Yang Sun, Xi-Ran Wang, Min-Ge Wang, Tang, Tian, Zhang, Yan, Liao, Xiao-Ping, Kreiswirth, Barry N., Shi-Dan Zhou, Huang, Bin, Du, Hong, Sun, Jian, Chen, Liang, Liu, Ya-Hong
Additional file 1: Figure S1. Sequence alignment of Tet(X) variants by ESPript version 3.0. Figure S2. Structural characteristics of Tet(X5)-like proteins. Figure S3. Resistance rates of the tet(X)-positive Acinetobacter spp. strains against 11 antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3a9b137cf87de9d052849681a67c011
